Hold COF with disciplined scale-in framework; breakout confirmed but internal weakness warrants waiting for pullback or Q3 validation
Hold with tiered scale-in framework; upgrade to Overweight on confirmation. Three consecutive validated Hold patterns (2026-08-07, 2026-08-10, 2026-08-11) establishing template. Forward EPS denominator at $24.05 is 25%+ above Q2 annualized run-rate of $19. Structural stop at $204; hard invalidation weekly close <$197.
| Position | Action |
|---|---|
| 1x benchmark weight | Neutral sizing due to unvalidated EPS denominator, goodwill tail risk, and missing sentiment data ahead of September FOMC and Q3 2026 catalyst window |
BUY COF because the stock trades at a 9.25x forward P/E with 32% earnings growth (PEG 0.23), delivered the strongest quarter in the dataset (Q2 2026: $15.85B revenue, $4.73 EPS), and benefits structurally from hawkish Fed policy (98% probability) via NIM expansion on its variable-rate card book—all while breaking out above multi-month resistance with a golden cross loading and returning 9.5% of market cap annually to shareholders.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 217.55 | bullish |
| close_50_sma | 202.32 | bullish |
| close_200_sma | 206.57 | bullish |
| rsi_14 | 65.93 | bullish |
| macd_line | 5.29 | bullish |
| macd_signal | 4.71 | bullish |
| macd_histogram | 0.58 | bearish |
| boll_upper_band | 226.67 | neutral |
| boll_middle_band | 212.20 | bullish |
| boll_lower_band | 197.73 | bullish |
| atr_14 | 5.15 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Then: Scale in 50% of target position
↩ rebuts: “Bear's 'wait and see' stance”
EV: +3-to-1 upside-to-downside on a 3-6 month horizon · concedes: Legal/regulatory overhang is acknowledged as a caveat, though argued to be already priced in; MACD histogram is cooling, though framed as normal within a confirmed breakout; Restructuring charges (~$400M in Q2 2026) still present, though net income jumped despite them
COF's bull thesis is built on unvalidated forward earnings ($24.05), ignores material unpriced risks (legal overhang, goodwill impairment, AOCI losses, restructuring drag), and presents a ~1:1 risk/reward rather than the claimed 3:1 — making the current $222 entry a buy of hope, not value.
· concedes: The $210–$212 breakout is real and price structure has improved; COF did generate a 102% return over three years despite legal overhang (though past returns don't validate present risk)
→ vs conservative: Conservative framing ignores that restructuring charges of 394 to 415 million in Q1 and Q2 occurred alongside tripled buyback cadence, signaling management confidence rather than distress; the goodwill concern reads the balance sheet but misses capital allocation behavior
→ vs conservative: ROE of 9% is a transition-state argument, not structural; stripping out the $32 billion goodwill load shows meaningful upside and ROE has 200 to 400 basis points of expansion potential as integration completes
→ vs conservative: Technical concerns about MACD divergence are contextually misleading; the stock just broke out of a six-month basing pattern above the 210-212 ceiling with MACD line freshly bullish above signal as of August 3rd
→ vs neutral: Forward earnings denominator concern is fair but stress-testing shows even a 15% haircut to $24.05 yields $20.40 EPS and 10.7x forward P/E, still dramatically cheap versus sector multiples
→ vs neutral: Neutral framing of RSI at 65.9 as a momentum warning is technically accurate in isolation but contextually misleading given the fresh breakout from six-month basing pattern
→ vs neutral: Waiting for retail confirmation from StockTwits and Reddit is backward; absence of meme chatter means institutional money accumulating; Cramer endorsement plus breakout highs signals stealth accumulation phase
→ vs neutral: Hold-and-let-NIM-expand framing is too passive given 9.5% annualized capital return yield provides a built-in yield floor; waiting leaves money on the table
→ vs neutral: Legal overhang is a known, priced-in discount at 9.25x forward earnings; the market has already been pricing it while stock compounded at ~26% CAGR; if it resolves, multiple expansion follows; if not, buybacks and NII growth earn through it
| neutral |
Support: 197.73 · 202.32 · 206.57 · 212.2 · 217.55 | Resistance: 226.67 · 240 · 246 · 247
COF is in a confirmed uptrend leg after breaking above the $210–$212 multi-month ceiling to close at $222.44. All timeframes are turning bullish: price above the 10 EMA ($217.55), 50 SMA ($202.32), and 200 SMA ($206.57), with the 50/200 golden cross expected in 6–8 sessions. The primary bearish signal is the MACD histogram (0.58) declining for five consecutive sessions despite price making new highs — a momentum divergence warning flag. ATR compression to 5.15 indicates a coiled spring primed for a larger directional move. The report favors a pullback-to-10-EMA scenario as the higher-probability near-term trade, with a confirmed close above $226.67 needed to unlock targets at $235–$247.
Market Capitalization
$136.46 billion
P/E Ratio (TTM)
12.26x
Forward P/E
9.25x
PEG Ratio
0.23
Price/Book
1.33x
EPS (TTM)
$18.15
Forward EPS
$24.05
Dividend Yield
1.46%
Beta
1.016
52-Week High
$259.64
52-Week Low
$174.24
50-Day Moving Average
$201.56
200-Day Moving Average
$207.60
Revenue (TTM)
$48.11 billion
Net Income (TTM)
$9.82 billion
Profit Margin (TTM)
21.87%
Operating Margin (TTM)
33.63%
Return on Equity (TTM)
9.03%
Return on Assets (TTM)
1.52%
Revenue 2022
$34.25 billion
Net Income 2022
$7.36 billion
EPS 2022
$17.91
Revenue 2023
$36.79 billion
Net Income 2023
$4.89 billion
EPS 2023
$11.95
Revenue 2024
$39.11 billion
Net Income 2024
$4.75 billion
EPS 2024
$11.59
Revenue 2025
$53.43 billion
Net Income 2025
$2.45 billion
EPS 2025
$4.03
Q2 2025 Revenue
$12.49 billion
Q2 2025 Net Income
-$4.27 billion
Q2 2025 EPS
-$8.58
Q3 2025 Revenue
$15.46 billion
Q3 2025 Net Income
$3.19 billion
Q3 2025 EPS
$4.83
Q4 2025 Revenue
$15.39 billion
Q4 2025 Net Income
$2.13 billion
Q4 2025 EPS
$3.26
Q1 2026 Revenue
$15.23 billion
Q1 2026 Net Income
$2.17 billion
Q1 2026 EPS
$3.34
Q2 2026 Revenue
$15.85 billion
Q2 2026 Net Income
$3.02 billion
Q2 2026 EPS
$4.73
Net Interest Income (TTM)
$43 billion
Q2 2026 NII
$12.37 billion
Q2 2026 Interest Income
$16.39 billion
Q2 2026 Interest Expense
$4.01 billion
Net Interest Margin
~7.5%
Total Assets 2022
$455.2 billion
Equity 2022
$52.6 billion
Total Assets 2023
$478.5 billion
Equity 2023
$58.1 billion
Total Assets 2024
$490.1 billion
Equity 2024
$60.8 billion
Total Assets 2025
$669.0 billion
Equity 2025
$113.6 billion
Total Assets Q2 2026
$673.84 billion
Total Equity Q2 2026
$113.79 billion
Cash & Equivalents Q2 2026
$54.71 billion
Available-for-Sale Securities Q2 2026
$88.02 billion
Goodwill & Intangibles Q2 2026
$47.94 billion
Goodwill 2024
$15.06 billion
Goodwill Q2 2026
$31.87 billion
Total Debt Q2 2026
$44.68 billion
Tangible Book Value Q2 2026
$65.85 billion
Book Value Per Share Q2 2026
$167.86
Leverage Ratio Q2 2026
5.92x
Treasury Stock Q2 2026
$14.27 billion
AOCI Losses
-$6.3 billion
Q2 2025 Operating Cash Flow
$6.07 billion
Q2 2025 CapEx
$0.40 billion
Q2 2025 Free Cash Flow
$5.67 billion
Q3 2025 Operating Cash Flow
$9.15 billion
Q3 2025 CapEx
$0.39 billion
Q3 2025 Free Cash Flow
$8.77 billion
Q4 2025 Operating Cash Flow
$7.83 billion
Q4 2025 CapEx
$0.44 billion
Q4 2025 Free Cash Flow
$7.39 billion
Q1 2026 Operating Cash Flow
$6.02 billion
Q1 2026 CapEx
$0.55 billion
Q1 2026 Free Cash Flow
$5.47 billion
Q2 2026 Operating Cash Flow
$8.44 billion
Q2 2026 CapEx
$0.37 billion
Q2 2026 Free Cash Flow
$8.08 billion
Annual FCF Run-Rate
$25-30 billion
Annual CapEx Estimate
$1.5-2 billion
Q2 2025 Buybacks
$0.67 billion
Q2 2025 Dividends
$0.39 billion
Q3 2025 Buybacks
$1.04 billion
Q3 2025 Dividends
$0.39 billion
Q4 2025 Buybacks
$2.52 billion
Q4 2025 Dividends
$0.51 billion
Q1 2026 Buybacks
$2.79 billion
Q1 2026 Dividends
$0.50 billion
Q2 2026 Buybacks
$2.75 billion
Q2 2026 Dividends
$0.50 billion
Annual Buybacks Run-Rate
~$13 billion
Q2 2026 Debt Repaid
$6.78 billion
Q1 2026 Debt Issued
$3.53 billion
Q1 2026 Debt Repaid
$2.48 billion
Net Debt Repayment Q2 2026
$7.31 billion
2025 Special/Restructuring Charges
$1.1 billion
2025 Interest Expense
$15.82 billion
2025 SG&A
$18.36 billion
Q1 2026 Restructuring Charges
$394-415 million
Q2 2026 Restructuring Charges
$394-415 million
Interest Expense 2024
$14.83 billion
Total Debt 2025
$50.4 billion
Strengths
Concerns
Capital One's $53.43B revenue in 2025 (up 36.6%) was overshadowed by a net income collapse to $2.45B and EPS of $4.03 due to $1.1B in special charges and doubled SG&A ($18.36B) from Discovery integration, with the acquisition closing mid-2025 concentrating costs. Q2 2026 shows strong sequential improvement with EPS of $4.73 (up 42% from Q1's $3.34), $8.08B FCF, and net debt deleveraging of $7.31B, while the balance sheet scaled dramatically to $673.84B in assets and $113.79B in equity post-Discovery. The investment case hinges on whether the sub-10x forward P/E (9.25x), 0.23 PEG ratio, ~$25-30B annual FCF, and ~$13B annual buyback program can offset persistent restructuring charges, below-average ROE (9.03%), and cyclical credit risk in an increasingly uncertain consumer environment.
Macro: Hawkish-tilt soft-landing regime with Polymarket pricing September FOMC at 66% hold + 32% hike + 1% cut, 86% odds of zero cuts in 2026, and only 8% recession odds by year-end. U.S. equities mixed after inflation data and AI earnings (Aug 12 window). TSX financials at fresh record high. Oil climbing with global stocks. Commodities (copper, silver, gold) mixed. No FRED macro data available this session.